APA (7th ed.) Citation

Hu, Q., Li, C., Zhang, T., Yi, L., Shan, Y., Ma, X., . . . Li, Y. (2024, September). Dihydromyricetin suppresses endothelial NLRP3 inflammasome activation and attenuates atherogenesis by promoting mitophagy. Lipids in Health and Disease.

Chicago Style (17th ed.) Citation

Hu, Qin, et al. "Dihydromyricetin Suppresses Endothelial NLRP3 Inflammasome Activation and Attenuates Atherogenesis by Promoting Mitophagy." Lipids in Health and Disease Sep. 2024.

MLA (9th ed.) Citation

Hu, Qin, et al. "Dihydromyricetin Suppresses Endothelial NLRP3 Inflammasome Activation and Attenuates Atherogenesis by Promoting Mitophagy." Lipids in Health and Disease, Sep. 2024.